AGEN
Agenus Inc
Price:  
4.79 
USD
Volume:  
811,447.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Agenus EV/EBITDA

68.7%
Upside

As of 2026-04-18, the EV/EBITDA ratio of Agenus Inc (AGEN) is -39.27. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Agenus's latest enterprise value is 493.85 mil USD. Agenus's TTM EBITDA according to its financial statements is -12.58 mil USD. Dividing these 2 quantities gives us the above Agenus EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.2x - 15.9x 14.1x
Forward P/E multiples 11.4x - 17.7x 14.4x
Fair Price (13.12) - 39.06 8.08
Upside -373.9% - 715.4% 68.7%
4.79 USD
Stock Price
8.08 USD
Fair Price

Agenus EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-16 -38.84
2026-04-15 -39.38
2026-04-14 -39.07
2026-04-13 -37.43
2026-04-10 -36.88
2026-04-09 -38.29
2026-04-08 -37.57
2026-04-07 -37.17
2026-04-06 -36.34
2026-04-02 -35.07
2026-04-01 -35.27
2026-03-31 -35.10
2026-03-30 -34.81
2026-03-27 -35.24
2026-03-26 -35.39
2026-03-25 -35.73
2026-03-24 -35.73
2026-03-23 -36.11
2026-03-20 -36.16
2026-03-19 -36.45
2026-03-18 -36.31
2026-03-17 -36.97
2026-03-16 -34.96
2026-03-13 -34.41
2026-03-12 -34.07
2026-03-11 -35.01
2026-03-10 -35.19
2026-03-09 -34.55
2026-03-06 -34.01
2026-03-05 -33.89
2026-03-04 -34.70
2026-03-03 -34.64
2026-03-02 -35.10
2026-02-27 -35.07
2026-02-26 -35.16
2026-02-25 -34.78
2026-02-24 -34.75
2026-02-23 -34.32
2026-02-20 -34.30
2026-02-19 -34.73
2026-02-18 -34.35
2026-02-17 -34.27
2026-02-13 -33.89
2026-02-12 -33.69
2026-02-11 -34.07
2026-02-10 -34.32
2026-02-09 -34.07
2026-02-06 -33.95
2026-02-05 -33.46
2026-02-04 -33.81